“Having many drugs available, choosing the most suitable drug for the patient, especially in relation to what his plan and lifestyle may be, I believe is an additional opportunity”. Thus Francesco Patti, professor of Neurology at the University of Catania, speaking on the sidelines of the two-day event organized by Merck in Milan and entitled 'Space of care: as one for patients'. At the center of the event are the new therapeutic frontiers for the treatment of highly active relapsing multiple sclerosis, among which cladribine in tablets stands out for its effectiveness, safety and manageability.
#Multiple #sclerosis #Patti #Choosing #suitable #drug #patient #additional #possibility
